10.1182/blood-2012-01-405365 - A foundation for universal T-cell bas...

This document has been corrected

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR

10.1182/blood-2012-01-405365

Published Online: 2012-06-14

Journal: Blood•Publisher: American Society of Hematology

Authors: Andreas Reik•Brian Rabinovitch•Chiara Bonini•Dean A. Lee•Edward J. Rebar•Helen Huls•Hiroki Torikai•Jeffrey C. Miller•Laurence J. N. Cooper•Ling Zhang•Luigi Naldini•Michael C. Holmes•Partow Kebriaei•Pei-Qi Liu•Philip D. Gregory•Richard E. Champlin•Sourindra Maiti•Yuanyue Zhou

This document has been corrected

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR

10.1182/blood-2012-01-405365

Published Online: 2012-06-14

Journal: Blood

NOW

2015-11-26•Erratum

Torikai H, Reik A, Liu P-Q, et al. A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR. Blood. 2012;119(24):5697-5705.

10.1182/blood-2015-10-675991

* information provided by CrossRef

2015-11-26•Erratum

10.1182/blood-2015-10-675991

* information provided by CrossRef

2012-06-14•Published

2015-11-26•Erratum

10.1182/blood-2015-10-675991

* information provided by CrossRef

This document has been corrected

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR

10.1182/blood-2012-01-405365

Published Online: 2012-06-14

Journal: Blood•Publisher: American Society of Hematology